PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial

Back

ESC Professional Premium Access

PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial

Session: Inflammatory mechanisms in vascular disease

Topic: Leukocytes, Inflammation, Immunity

Speaker: Ms A. Ondracek (Vienna, AT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Ms Anna S Ondracek

Vienna (Austria)

0 follower

6 more presentations in this session

Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils

Speaker: Doctor S. Eiras (Santiago de Compostela, ES)

Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes

Speaker: Mr J. Bernhard (Vienna, AT)

Bone-marrow-derived nerve growth factor receptor-positive dendritic cells contribute to the suppression of arterial remodelling via apoptosis

Speaker: Assistant Professor S. Takashima (Kanazawa, JP)

Phenylacetylglutamine causes a pathologic inflammation state and enhances atherosclerosis through the b2-adrenergic receptor cAMP PKA NF-kappaB pathway in diabetes.

Speaker: Doctor L. Huang (Shanghai, CN)

The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model

Speaker: Doctor B. Barta (Budapest, HU)

Access the full session

Inflammatory mechanisms in vascular disease

Speakers: Ms A. Ondracek, Doctor S. Eiras, Mr J. Bernhard, Assistant Professor S. Takashima, Doctor L. Huang...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources